Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:OPRX
FechaHoraFuenteTítuloSímboloCompañía
11/06/202416:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
10/06/202408:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPRXOptimizeRx Corporation
07/06/202415:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
15/05/202416:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPRXOptimizeRx Corporation
06/05/202420:34Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:OPRXOptimizeRx Corporation
14/02/202416:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OPRXOptimizeRx Corporation
09/01/202415:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPRXOptimizeRx Corporation
05/01/202416:19Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OPRXOptimizeRx Corporation
30/10/202315:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
20/06/202307:00GlobeNewswire Inc.LifeMD Appoints William J. Febbo to its Board of DirectorsNASDAQ:OPRXOptimizeRx Corporation
09/06/202315:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OPRXOptimizeRx Corporation
07/06/202315:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
25/04/202315:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OPRXOptimizeRx Corporation
20/04/202314:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
10/03/202315:57Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OPRXOptimizeRx Corporation
10/03/202315:53Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:OPRXOptimizeRx Corporation
10/03/202315:47Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:OPRXOptimizeRx Corporation
03/03/202317:56PR Newswire (US)Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NASDAQ:OPRXOptimizeRx Corporation
09/02/202310:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPRXOptimizeRx Corporation
10/11/202219:49TipRanksOptimizeRx (OPRX) Receives a Buy from RBC CapitalNASDAQ:OPRXOptimizeRx Corporation
09/11/202222:30TipRanksAnalysts Offer Insights on Technology Companies: Activision Blizzard (ATVI), OptimizeRx (OPRX) and Embark Technology, Inc. (EMBK)NASDAQ:OPRXOptimizeRx Corporation
09/11/202209:25TipRanksOptimizeRx (OPRX) Gets a Buy from B.Riley FinancialNASDAQ:OPRXOptimizeRx Corporation
08/11/202215:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPRXOptimizeRx Corporation
03/10/202213:59Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPRXOptimizeRx Corporation
14/09/202220:46TipRanksRBC Capital Keeps Their Buy Rating on OptimizeRx (OPRX)NASDAQ:OPRXOptimizeRx Corporation
19/08/202215:46Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OPRXOptimizeRx Corporation
10/08/202207:05TipRanksB.Riley Financial Sticks to Their Buy Rating for OptimizeRx (OPRX)NASDAQ:OPRXOptimizeRx Corporation
10/08/202207:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OPRXOptimizeRx Corporation
25/07/202209:13TipRanksDown More Than 50%: These 2 ‘Strong Buy’ Stocks Are Trading at Rock-Bottom PricesNASDAQ:OPRXOptimizeRx Corporation
20/07/202206:25TipRanksB.Riley Financial Remains a Buy on OptimizeRx (OPRX)NASDAQ:OPRXOptimizeRx Corporation
 Showing the most relevant articles for your search:NASDAQ:OPRX